Cargando…

Circulating Fibroblast Activation Protein as Potential Biomarker in Patients With Inflammatory Bowel Disease

A major concern in the management of Inflammatory Bowel Disease (IBD) is the absence of accurate and specific biomarkers to drive diagnosis and monitor disease status timely and non-invasively. Fibroblast activation protein (FAP) represents a hallmark of IBD bowel strictures, being overexpressed in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Corsi, Fabio, Sorrentino, Luca, Albasini, Sara, Colombo, Francesco, Cigognini, Maria, Massari, Alessandro, Morasso, Carlo, Mazzucchelli, Serena, Piccotti, Francesca, Ardizzone, Sandro, Sampietro, Gianluca M., Truffi, Marta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8490650/ https://www.ncbi.nlm.nih.gov/pubmed/34621763 http://dx.doi.org/10.3389/fmed.2021.725726

Ejemplares similares

Nano-Strategies to Target Breast Cancer-Associated Fibroblasts: Rearranging the Tumor Microenvironment to Achieve Antitumor Efficacy
por: Truffi, Marta, et al.
Publicado: (2019)

Prediction of nodal staging in breast cancer patients with 1-2 sentinel nodes in the Z0011 era
por: Corsi, Fabio, et al.
Publicado: (2020)

Preoperative Systemic Inflammatory Biomarkers Are Independent Predictors of Disease Recurrence in ER+ HER2- Early Breast Cancer
por: Truffi, Marta, et al.
Publicado: (2021)

Fast quantification of extracellular vesicles levels in early breast cancer patients by Single Molecule Detection Array (SiMoA)
por: Morasso, Carlo, et al.
Publicado: (2021)

Novel Bioengineering Strategies to Improve Bioavailability and In Vivo Circulation of H-Ferritin Nanocages by Surface Functionalization
por: Sevieri, Marta, et al.
Publicado: (2023)

Anti-MAdCAM-1-Conjugated Nanocarriers Delivering Quantum Dots Enable Specific Imaging of Inflammatory Bowel Disease
por: Truffi, Marta, et al.
Publicado: (2020)

Prognostic Potential of Immune Inflammatory Biomarkers in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy
por: Truffi, Marta, et al.
Publicado: (2022)

Selective Targeting of Cancer-Associated Fibroblasts by Engineered H-Ferritin Nanocages Loaded with Navitoclax
por: Sitia, Leopoldo, et al.
Publicado: (2021)

Whitlockite has a characteristic distribution in mammary microcalcifications and it is not associated with breast cancer
por: Morasso, Carlo, et al.
Publicado: (2023)

Combined Method to Remove Endotoxins from Protein Nanocages for Drug Delivery Applications: The Case of Human Ferritin
por: Silva, Filippo, et al.
Publicado: (2021)

Multivalent exposure of trastuzumab on iron oxide nanoparticles improves antitumor potential and reduces resistance in HER2-positive breast cancer cells
por: Truffi, Marta, et al.
Publicado: (2018)

Lipofilling in Breast Oncological Surgery: A Safe Opportunity or Risk for Cancer Recurrence?
por: Piccotti, Francesca, et al.
Publicado: (2021)

Ultrastructural analysis of breast cancer patient-derived organoids
por: Signati, Lorena, et al.
Publicado: (2021)

Has the Removing of the Mesentery during Ileo-Colic Resection an Impact on Post-Operative Complications and Recurrence in Crohn’s Disease? Results from the Resection of the Mesentery Study (Remedy)
por: Mineccia, Michela, et al.
Publicado: (2022)

Repeated surgery for recurrent Crohn’s disease: does the outcome keep worsening operation after operation? A comparative study of 1224 consecutive procedures
por: Colombo, Francesco, et al.
Publicado: (2021)

Nanometronomic treatment of 4T1 breast cancer with nanocaged doxorubicin prevents drug resistance and circumvents cardiotoxicity
por: Mazzucchelli, Serena, et al.
Publicado: (2016)

Tumor Accumulation and Off-Target Biodistribution of an Indocyanine-Green Fluorescent Nanotracer: An Ex Vivo Study on an Orthotopic Murine Model of Breast Cancer
por: Sevieri, Marta, et al.
Publicado: (2021)

Establishment and Morphological Characterization of Patient-Derived Organoids from Breast Cancer
por: Mazzucchelli, S., et al.
Publicado: (2019)

Neurofilament-light chain quantification by Simoa and Ella in plasma from patients with dementia: a comparative study
por: Truffi, Marta, et al.
Publicado: (2023)

Indocyanine Green Nanoparticles: Are They Compelling for Cancer Treatment?
por: Sevieri, Marta, et al.
Publicado: (2020)

Protein-Based Nanoparticles for the Imaging and Treatment of Solid Tumors: The Case of Ferritin Nanocages, a Narrative Review
por: Mainini, Francesco, et al.
Publicado: (2021)

Everolimus Nanoformulation in Biological Nanoparticles Increases Drug Responsiveness in Resistant and Low-Responsive Breast Cancer Cell Lines
por: Bonizzi, Arianna, et al.
Publicado: (2019)

Development of Tumor-Targeted Indocyanine Green-Loaded Ferritin Nanoparticles for Intraoperative Detection of Cancers
por: Sitia, Leopoldo, et al.
Publicado: (2020)

Sequential Approach for a Critical-View COlectomy (SACCO): A Laparoscopic Technique to Reduce Operative Time and Complications in IBD Acute Severe Colitis
por: Sampietro, Gianluca Matteo, et al.
Publicado: (2020)

Raman spectroscopy determination of the mineral characteristics of microcalcifications in breast cancer: a way towards an improved screening approach
por: Corsi, Fabio, et al.
Publicado: (2021)

In Vitro Immunoreactivity Evaluation of H-Ferritin-Based Nanodrugs
por: Sitia, Leopoldo, et al.
Publicado: (2023)

Bisdemethoxycurcumin (BDC)-Loaded H-Ferritin-Nanocages Mediate the Regulation of Inflammation in Alzheimer’s Disease Patients
por: Gagliardi, Stella, et al.
Publicado: (2022)

Quantification and prospective evaluation of serum NfL and GFAP as blood-derived biomarkers of outcome in acute ischemic stroke patients
por: Ferrari, Federica, et al.
Publicado: (2023)

Co-administration of H-ferritin-doxorubicin and Trastuzumab in neoadjuvant setting improves efficacy and prevents cardiotoxicity in HER2 + murine breast cancer model
por: Andreata, F., et al.
Publicado: (2020)

H-Ferritin-nanocaged olaparib: a promising choice for both BRCA-mutated and sporadic triple negative breast cancer
por: Mazzucchelli, S., et al.
Publicado: (2017)

Theranostic application of miR-429 in HER2+ breast cancer
por: Cava, Claudia, et al.
Publicado: (2020)

HDL Dysfunctionality: Clinical Relevance of Quality Rather Than Quantity
por: Bonizzi, Arianna, et al.
Publicado: (2021)

Biologic targeting in the treatment of inflammatory bowel diseases
por: Bosani, Matteo, et al.
Publicado: (2009)

Personalize, participate, predict, and prevent: 4Ps in inflammatory bowel disease
por: Lenti, Marco Vincenzo, et al.
Publicado: (2023)

Dermatological Manifestations in Inflammatory Bowel Diseases
por: Antonelli, Elisabetta, et al.
Publicado: (2021)

Therapeutic Management of Adults with Inflammatory Bowel Disease and Malignancies: A Clinical Challenge
por: Ferretti, Francesca, et al.
Publicado: (2023)

Relevance of sonographic parameters for inflammatory bowel disease in children
por: Dell’Era, Alessandra, et al.
Publicado: (2023)

A Bioorthogonal Probe for Multiscale Imaging by (19)F-MRI and Raman Microscopy: From Whole Body to Single Cells
por: Chirizzi, Cristina, et al.
Publicado: (2021)

HER-2-Targeted Nanoparticles for Breast Cancer Diagnosis and Treatment
por: Sitia, Leopoldo, et al.
Publicado: (2022)

Full-Length Recombinant hSP-D Binds and Inhibits SARS-CoV-2
por: Arroyo, Raquel, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_sen91h6m24ch5gttgd2t8v5obn